4Mahajan R, Brooks AG, Sullivan T, et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart, 2012, 98:1120-1126. Whitlock RP, Vincent J, Blackall MH, et al. Left Atrial Appendage Occlusion Study II (LAAOS II). Can J Cardiol, 2013, 29: 1443-1447.
5Toumanides S, Sideris EB, Agricola T, et al. Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high- risk patients with atrial fibrillation. J Am Coil Cardiol, 2011, 58: 2236-2240.
7Stone D, Byrne T, Pershad A. Early Results With the LARIAT Device for Left Atrial Appendage Exclusion in Patients With Atrial Fibrillation at High Risk for Stroke and Anticoagulation. Catheter Cardiovasc Interv, 2013, doi: 10. 1002. [Epub ahead of print].
8Nakai T, Lesh MD, Gerstenfeld EP, et al. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation, 2002, 105: 2217-2222.
9Ostermayer SH, Reismau M, Kramer PH, et al. Percutaueous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coil Cardiol, 2005, 46: 9-14.
10Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coil Cardiol, 2005, 46: 9-14.